Assyro AI

Orange Book product · Brand (NDA)

KONVOMEP

OMEPRAZOLE; SODIUM BICARBONATE

Brand (NDA)NDA 213593RX AZURITY

At a glance

Aug 30, 2022

Approved

Brand (NDA)

Application

Not listed

TE code

9

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 30, 2022

    3 yr 10 mo ago

  2. Today

  3. Patent 10751333 expires

    Listed drug product patent expiration.

    Jul 16, 2039

    in 13 yr 3 mo

  4. Patent 11103492 expires

    Listed drug product patent expiration.

    Jul 16, 2039

    in 13 yr 3 mo

  5. Patent 11633478 expires

    Listed drug product patent expiration.

    Jul 16, 2039

    in 13 yr 3 mo

  6. Patent 11911473 expires

    Listed method-of-use patent (U-623) expiration.

    Jul 16, 2039

    in 13 yr 3 mo

  7. Patent 11911473 expires

    Listed method-of-use patent (U-624) expiration.

    Jul 16, 2039

    in 13 yr 3 mo

  8. Patent 12042539 expires

    Listed drug product patent expiration.

    Jul 16, 2039

    in 13 yr 3 mo

  9. Patent 12329752 expires

    Listed drug product patent expiration.

    Jul 16, 2039

    in 13 yr 3 mo

  10. Patent 12440566 expires

    Listed drug product patent expiration.

    Jul 16, 2039

    in 13 yr 3 mo

  11. Patent 11771686 expires

    Listed method-of-use patent (U-623) expiration.

    Mar 01, 2040

    in 13 yr 11 mo

Pharmaceutical detail

Active ingredient

OMEPRAZOLE; SODIUM BICARBONATE

Strength

2MG/ML;84MG/ML

Dosage form

FOR SUSPENSION

Route

ORAL

TE code

Not listed

Application

NDA 213593

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (9)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10751333Jul 16, 2039in 13 yr 3 mo
Product
11103492Jul 16, 2039in 13 yr 3 mo
Product
11633478Jul 16, 2039in 13 yr 3 mo
Product
11911473Jul 16, 2039in 13 yr 3 mo
U-623
11911473Jul 16, 2039in 13 yr 3 mo
U-624
12042539Jul 16, 2039in 13 yr 3 mo
Product
12329752Jul 16, 2039in 13 yr 3 mo
Product
12440566Jul 16, 2039in 13 yr 3 mo
Product
11771686Mar 01, 2040in 13 yr 11 mo
U-623
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.